Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CNP-PTX
- Development stage
- Preclinical
- Lead developer
- SiNON Nano Sciences
- Modality
- Nanoparticles → Drug Delivery Systems, Small Molecules
01
Overview
CNP-PTX (also known as CNPPTX-1002) is a preclinical-stage drug delivery system developed by SiNON Nano Sciences. It utilizes proprietary Carbon NanoDots (CNDs) as a delivery vehicle to encapsulate and transport the chemotherapy agent paclitaxel. The platform is specifically engineered to cross the blood-brain barrier (BBB), addressing a significant challenge in treating glioblastoma and other brain tumors. By targeting the delivery of paclitaxel directly to tumor cells, the system aims to enhance therapeutic efficacy while reducing systemic toxicity associated with conventional chemotherapy. The carbon nanoparticle delivery system is designed to release the payload specifically at tumor sites rather than healthy tissues.
- Other names
- Paclitaxel-loaded carbon nanoparticles
02
Targets
TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on CNP-PTX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CNP-PTX.